Replimune Group, Inc. (REPL)
5.22
+0.29
(+5.88%)
USD |
NASDAQ |
May 15, 16:00
5.18
-0.04
(-0.77%)
After-Hours: 20:00
Replimune Group Total Liabilities (Quarterly) : 123.05M for Dec. 31, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| REGENXBIO, Inc. | 320.81M |
| Catalyst Pharmaceuticals, Inc. | 134.91M |
| Spyre Therapeutics, Inc. | 93.14M |
| Bristol Myers Squibb Co. | 66.37B |
| ANI Pharmaceuticals, Inc. | 859.67M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 333.59M |
| Shareholders Equity (Quarterly) | 210.54M |
| Debt to Equity Ratio | 0.3626 |
| Current Ratio | 5.597 |
| Net Debt Paydown Yield | -0.01% |